News|Articles|July 2, 2003
- Pharmaceutical Technology-07-02-2003
- Volume 27
- Issue 7
Capacity Worries Fade for Biomanufacturing
Author(s)Jim Miller
The DSM investment puts biomanufacturing capacity in the spotlight. Contract biomanufacturers are adding new capacity and sponsors are marketing their excess capacity.
Advertisement
Articles in this issue
over 22 years ago
July 2003over 22 years ago
The Push for Generics Challenges Manufacturersover 22 years ago
Emerging Research Opportunities in Oral Inhalation Technologyover 22 years ago
Preventing Metal ContaminationNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
2
PharmTech Weekly News Roundup – Week of December 1, 2025
3
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
4
Raman Spectroscopy—A Game-Changer in the Fight Against Counterfeit Drugs
5
